Otsuka Pharmaceutical Co., Ltd. et al v. Zenara Pharma Private Ltd. et al > Summary
Court Case Number 1:20-cv-01599
Filing Date Nov 24, 2020
Termination Date Oct 20, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesLeonard P. Stark
Plaintiff Attorneys
13Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Erin M. Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Erin M. Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
7Zenara Pharma Private Ltd.
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Zenara Pharma Private Ltd.
Attorney Name: Dmitry V. Shelhoff
Pergament & Cepeda LLP
Biophore India Pharmaceuticals Pvt. Ltd.
Attorney Name: Kenneth S. Canfield
Pergament & Cepeda LLP
Biophore India Pharmaceuticals Pvt. Ltd.
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Biophore India Pharmaceuticals Pvt. Ltd.
Attorney Name: Dmitry V. Shelhoff
Pergament & Cepeda LLP
Biophore India Pharmaceuticals Pvt. Ltd.
Attorney Name: Edward David Pergament
Pergament & Cepeda LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE048059 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jun 23, 2020 |
| 10307419 | Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof | Jun 4, 2019 |
| 07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |
